{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:25:41Z","timestamp":1761765941152},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.juro.2015.05.078","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T10:28:05Z","timestamp":1432204085000},"page":"1234-1240","source":"Crossref","is-referenced-by-count":6,"title":["Natural History of Pathologically Benign Cancer Suspicious Regions on Multiparametric Magnetic Resonance Imaging Following Targeted Biopsy"],"prefix":"10.1097","volume":"194","author":[{"given":"Darren J.","family":"Bryk","sequence":"first","affiliation":[{"name":"Department of Urology, Smilow Comprehensive Prostate Cancer Center, New York University School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elton","family":"Llukani","sequence":"additional","affiliation":[{"name":"Department of Urology, Smilow Comprehensive Prostate Cancer Center, New York University School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, Smilow Comprehensive Prostate Cancer Center, New York University School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Lepor","sequence":"additional","affiliation":[{"name":"Department of Urology, Smilow Comprehensive Prostate Cancer Center, New York University School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.05.078_bib1","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM200105033441806","article-title":"Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer","volume":"344","author":"Barry","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2015.05.078_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0090-4295(00)00993-6","article-title":"Prostate-specific antigen best practice policy\u2014part I:\u00a0early detection and diagnosis of prostate cancer","volume":"57","author":"Carroll","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.05.078_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2015.05.078_bib4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a\u00a0randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2015.05.078_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(17)38664-0","article-title":"Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate","volume":"142","author":"Hodge","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF00619953","article-title":"Multiple transrectal ultrasound-guided biopsies for the detection of prostate cancer and determination of tumor volume, grade, and seminal vesicle invasion","volume":"6","author":"Norberg","year":"1996","journal-title":"Eur Radiol"},{"key":"10.1016\/j.juro.2015.05.078_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.juro.2014.03.117","article-title":"Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment","volume":"192","author":"Bjurlin","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/02841850802004983","article-title":"Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined","volume":"49","author":"Chen","year":"2008","journal-title":"Acta Radiol"},{"key":"10.1016\/j.juro.2015.05.078_bib9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.juro.2011.05.078","article-title":"Magnetic resonance imaging\/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging","volume":"186","author":"Pinto","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib10","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.juro.2013.05.052","article-title":"Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer","volume":"190","author":"Rais-Bahrami","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib11","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.juro.2011.07.013","article-title":"Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds","volume":"186","author":"Turkbey","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1148\/radiol.09090475","article-title":"Prostate cancer: value of multiparametric MR imaging at 3 T for detection\u2014histopathologic correlation","volume":"255","author":"Turkbey","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.juro.2015.05.078_bib13","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.juro.2013.04.043","article-title":"Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer","volume":"190","author":"Kuru","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.eururo.2013.10.048","article-title":"A\u00a0prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial","volume":"66","author":"Wysock","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.juro.2012.08.095","article-title":"Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device","volume":"189","author":"Sonn","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1148\/radiol.13121501","article-title":"Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic\u00a0biopsy\u2014prospective multicenter study","volume":"268","author":"Puech","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.juro.2015.05.078_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.eururo.2013.03.025","article-title":"Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen","volume":"65","author":"Sonn","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1148\/radiol.13122233","article-title":"Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales","volume":"269","author":"Rosenkrantz","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.juro.2015.05.078_bib19","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.juro.2006.08.007","article-title":"Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings","volume":"176","author":"Villers","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clinimag.2014.08.008","article-title":"Association between changes in suspicious prostate lesions on serial MRI examinations and follow-up biopsy results","volume":"39","author":"Rosenkrantz","year":"2015","journal-title":"Clin Imaging"},{"key":"10.1016\/j.juro.2015.05.078_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5152\/dir.2014.13319","article-title":"Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up","volume":"20","author":"Rais-Bahrami","year":"2014","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.juro.2015.05.078_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.juro.2006.09.063","article-title":"Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening","volume":"177","author":"Moul","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.078_bib23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jnci\/djr028","article-title":"An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection","volume":"103","author":"Vickers","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.juro.2015.05.078_bib24","doi-asserted-by":"crossref","first-page":"20130659","DOI":"10.1259\/bjr.20130659","article-title":"Prostate cancer and its mimics at multiparametric prostate MRI","volume":"87","author":"Yu","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.juro.2015.05.078_bib25","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ejrad.2014.06.026","article-title":"Negative predictive value of multiparametric MRI for prostate cancer detection: outcome of 5-year follow-up in men with negative findings on initial MRI studies","volume":"83","author":"Itatani","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.juro.2015.05.078_bib26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2015.05.078_bib27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.juro.2015.05.078_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.urology.2007.05.010","article-title":"Prostate-specific antigen velocity risk count assessment: a new concept for detection of life-threatening prostate cancer during window of curability","volume":"70","author":"Carter","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.05.078_bib29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1464-410X.2011.10900.x","article-title":"Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer","volume":"109","author":"Loeb","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.05.078_bib30","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.2214\/AJR.12.10173","article-title":"Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI","volume":"201","author":"Rosenkrantz","year":"2013","journal-title":"AJR Am J Roentgenol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715040720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715040720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.05.078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:58:49Z","timestamp":1651204729000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.05.078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1016\/j.juro.2015.05.078"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.05.078","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}